Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system.
about
The gut microbiome in human immunodeficiency virus infectionSTART or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus InfectionCardiovascular Complications of HIV in Endemic Countries.Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.Incidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda.Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individualsHIV Infection and Acute Stroke: A Case Report and a Review of the Literature.HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationInitiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?Microbial translocation and cardiometabolic risk factors in HIV infection.HIV protease inhibitor exposure predicts cerebral small vessel disease.Epidemiology of coronary heart disease in patients with human immunodeficiency virusElevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort.Cardiovascular disease risk in an aging HIV population: not just a question of biology.Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapyStatin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque.HIV status and the risk of ischemic stroke among men.Clinical management of infectious cerebral vasculitides.Burden of stroke attributable to selected lifestyle risk factors in rural South Africa.Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study.Preventing Heart Failure in Inflammatory and Immune DisordersBrain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV.Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era.Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan AfricaHIV infection as vascular risk: A systematic review of the literature and meta-analysis.Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIVHigh Prevalence of Metabolic Syndrome and Cardiovascular Disease Risk Among People with HIV on Stable ART in Southwestern UgandaEffect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infectionHIV stroke risk: evidence and implications.Diagnostic delay in progressive multifocal leukoencephalopathy.Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States.Effects of smoking on non-AIDS-related morbidity in HIV-infected patients.Inflammation, immune activation, and cardiovascular disease in HIV.HIV-infected adolescent, young adult and pregnant smokers: important targets for effective tobacco control programs.Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men.The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis.
P2860
Q26743543-3E7C5FA9-04A2-4CE7-BDE6-9A5C0386929FQ26753830-897EDCAC-39A1-410A-A905-AC462AB84EBFQ30244655-D6241B8E-21AC-48DF-A20D-B2358B897619Q30248351-452F50BE-6E9B-4B45-86F6-E826D3F98722Q30278586-76BB5388-84A5-4A50-BA7C-CFB922F889E0Q30366554-8D8594BB-7FA2-444B-BD8A-FC9F16A3DC17Q30670446-7E4950F4-5B93-43A2-8154-AB6A69D076A9Q30839904-2A1FF37A-3E9B-440E-A864-18B1E9890A86Q33649200-48F67D26-E8D4-439E-B427-E61B2AE822BDQ33713895-568F603C-FDEA-45CA-AA03-54DD7CC0CC9FQ33807507-40764F0C-3853-43BE-A177-698109C551AFQ33998067-55CFD164-7550-4239-8DCE-BF184C2D010AQ34553819-8CE97819-B86C-4D58-9311-EA3238C02103Q35064091-AA849186-2CE0-4D7D-8DD0-F731ABC16D93Q35072103-A291C6CB-E1AD-4B2F-8242-3BD6DFF25E1AQ35146687-7A15FBF1-AFA0-41FF-A99F-B0AD5C3E1C82Q35190397-225E552D-1D7D-4CA3-8AFB-354D28D4E87BQ35508766-9BEFAA2F-5755-49E7-8035-7E85A7B346A9Q35510401-C63C59C6-8FD4-4155-952F-1B4EF8C17C42Q35611619-C2348433-E91C-4720-A5F6-1C6FAC6FF305Q35874045-E45EBAC7-C652-4D72-AC54-620263510C54Q35921606-6A4C4DE7-FA26-49DC-9162-9AF918E1CAE9Q35960698-22BEC64E-89C6-4374-A9CE-C92E61617541Q35994802-480F7519-4E5F-475C-A40D-469DFE6C50E5Q36156701-DFA203F6-480C-4A9F-BE10-DF8380A1E49EQ36284359-A1422FA4-EF78-4A8E-8E2C-D5BD92F8EA81Q36290172-6B41D861-A7B3-4667-967F-443266367A8DQ36368959-2D7B1EC7-B308-4B1E-B15D-4460D3E041C5Q36440262-A74355A3-C3AD-4414-A73D-BE8DCA942E1DQ36463715-91DA23F4-1FA2-4B07-A9DB-1E6D68F61B8DQ36475983-178B4627-2202-4296-8770-F23CFFB7D90BQ36551454-54EB353B-A5D2-4124-9CB8-C2992E8CF1BEQ36722756-FD98CAE6-6A7F-4836-BA55-E4FF70793C2BQ36891735-5D6351CE-D71D-415D-B885-27E0FAB761D1Q36937890-9A217C5F-7B6C-437E-BB20-B6152AF2F4D2Q36946246-CAD606E5-F8E5-4234-905F-B12F5464DDB7Q36957752-01808E1E-258A-4CB9-9672-62EC7849A133Q37030799-082861C0-6B1F-40F1-A8C7-B63CE1E6ACD7Q37392589-5231E390-BD3A-44A0-9D47-4E485BB7CBB4Q37528500-1949D9BD-1DDE-4F61-ACEC-C448C2583006
P2860
Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Comparison of ischemic stroke ...... ts in a US health care system.
@en
type
label
Comparison of ischemic stroke ...... ts in a US health care system.
@en
prefLabel
Comparison of ischemic stroke ...... ts in a US health care system.
@en
P2093
P2860
P1476
Comparison of ischemic stroke ...... ts in a US health care system.
@en
P2093
Felicia C Chow
Steven Feske
Steven K Grinspoon
Susan Regan
Virginia A Triant
P2860
P304
P356
10.1097/QAI.0B013E31825C7F24
P407
P577
2012-08-01T00:00:00Z